“…NKG2D ligands (NKG2DLs) are mainly induced on the surface of transformed, infected or otherwise “stressed” cells, while the expression on healthy cells is low. However, increasing evidences show that NKG2DLs can be constitutively expressed or induced on normal hematopoietic cells including bone marrow cells (Nowbakht et al, 2005; Poggi et al, 2005; Spaggiari et al, 2006), mature DCs (Jinushi et al, 2003a,b; Andoniou et al, 2005; Schrama et al, 2006; Galazka et al, 2007; Qiao et al, 2008), monocytes and macrophages (Hamerman et al, 2004; Nowbakht et al, 2005; Nedvetzki et al, 2007; Kloss et al, 2008; Schulz et al, 2010), B cells (Nowbakht et al, 2005), and T cells. In general, NKG2DLs are not expressed by resting T lymphocytes, but their expression can be induced by different stimuli ( Table 1 ).…”